Quarton International advised humediQ global GmbH on the sale to Varian Medical Systems, Inc.

Tombstone humediq 2018 englisch


Munich – Quarton International advised the sole shareholder of humediQ global GmbH (“humediQ”) on the sale of all shares to Varian Medical Systems, Inc. (“Varian”), a global leader in the radiotherapy of tumor diseases.


humediQ, headquartered in Munich, Germany, is focused on the development, production and sales of hardware and software solutions for quality assurance in radiotherapy. Key product of humediQ is IDENTIFY, an automated patient identification, positioning and motion management system for radiation therapy. IDENTIFY incorporates patient safety, quality, efficiency and surface-guided features in an automated workflow solution for surface-guided radiation therapy (SGRT). The IDENTIFY system features a palm reader for patient identification, a radio frequency identification (RFID) reader for proper accessory verification and placement on the treatment couch, automatic synchronization with the oncology information system, and SGRT cameras for proper patient positioning and motion monitoring throughout the treatment. For more information, visit www.humediq.com


Varian, headquartered in Palo Alto, California, is a leader in developing and delivering hardware and software products for the treatment of cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy (SBRT), proton therapy, and brachytherapy. Varian employs approximately 6,500 people around the world. For more information, visit www.varian.com




+49 89 2000 393 0



+49 89 2000 393 0

Customer Statements

After Quarton had already successfully organized the sale of my former company Medical Intelligence GmbH to Elekta AB, it was clear for me to trust Quarton's outstanding medical technology know-how and excellent service in this transaction as well. Despite our already high expectations, Quarton exceeded them in every respect, and through their competence and commitment made the transaction an extraordinary success.
Christian Hieronimi
Founder and CEO of humediQ

Similar Transactions

Tombstone WAZ Auctus 2022 en
Tombstone Hidden Inspire PSCHR 2022 en
Tombstone Watsonville PVHDP 2022 en
Tombstone Locum Doctors House of HR
Tombstone Kunze Aiutanda Carestone En1
Tombstone Akili Social Capital Suvretta 2022 en1
Tombstone EOS EMS en1
Tombstone Blueprint Strategic financing 2022
Tombstone Hidden Harbor 2022 En
Tombstone GVB Biopharma 22nd Century
Tombstone Ionpath Thermo Fisher 2022 En
Tombstone Opko Genedx Sema4 2022en